Page last updated: 2024-08-26

cyanopindolol and Morbid Obesity

cyanopindolol has been researched along with Morbid Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barakat, H; Christian, B; Davis, J; Hickner, R; McConnaughey, MM; Privette, J; Sheets, KA	1

Trials

1 trial(s) available for cyanopindolol and Morbid Obesity

Article	Year
Differences in beta-adrenergic receptor densities in omental and subcutaneous adipose tissue from obese African American and Caucasian women. Metabolism: clinical and experimental, 2004, Volume: 53, Issue:2 Topics: Adipose Tissue; Adrenergic beta-Agonists; Adult; Black or African American; Cell Membrane; Female; Humans; Immunoblotting; Isoproterenol; Kinetics; Lipolysis; Obesity, Morbid; Omentum; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; White People	2004

Article

Year

Differences in beta-adrenergic receptor densities in omental and subcutaneous adipose tissue from obese African American and Caucasian women.

Metabolism: clinical and experimental, 2004, Volume: 53, Issue:2

Topics: Adipose Tissue; Adrenergic beta-Agonists; Adult; Black or African American; Cell Membrane; Female; Humans; Immunoblotting; Isoproterenol; Kinetics; Lipolysis; Obesity, Morbid; Omentum; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; White People

2004